Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

NCT06446388 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: QLS31905
DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: QL1706
DRUG: Chemotherapy drug

Sponsor

Qilu Pharmaceutical Co., Ltd.